BIO 300, a nanosuspension of genistein, mitigates radiation-induced erectile dysfunction and sensitizes human prostate cancer xenografts to radiation therapy

To assess whether BIO 300, a synthetic genistein nanosuspension, improves the therapeutic index in prostate cancer treatment by preventing radiation-induced erectile dysfunction (ED) without reducing tumor radiosensitivity.

Source: International Journal of Radiation Oncology * Biology * Physics - June 4, 2019 Category: Radiology Authors: Isabel L. Jackson, Rada Pavlovic, Allen A. Alexander, Caroline Q. Connors, Diana Newman, Javed Mahmood, John Eley, Adam J. Harvey, Michael D. Kaytor, Zeljko Vujaskovic Source Type: research